Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Shares Outstanding (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed Shares Outstanding for 10 consecutive years, with $49.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding rose 0.89% to $49.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $49.7 million, a 0.89% increase, with the full-year FY2024 number at $49.4 million, up 0.59% from a year prior.
  • Shares Outstanding was $49.7 million for Q3 2025 at KORU Medical Systems, roughly flat from $49.7 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $49.7 million in Q3 2025 to a low of $47.9 million in Q1 2021.
  • A 5-year average of $48.8 million and a median of $49.0 million in 2023 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: rose 12.9% in 2021, then grew 0.37% in 2024.
  • KORU Medical Systems' Shares Outstanding stood at $48.0 million in 2021, then grew by 1.7% to $48.9 million in 2022, then grew by 0.47% to $49.1 million in 2023, then increased by 0.59% to $49.4 million in 2024, then rose by 0.68% to $49.7 million in 2025.
  • Per Business Quant, the three most recent readings for KRMD's Shares Outstanding are $49.7 million (Q3 2025), $49.7 million (Q2 2025), and $49.6 million (Q1 2025).